系统性红斑狼疮中的I型干扰素系统。 - Suppr

Suppr

超能文献

The type I interferon system in systemic lupus erythematosus.

作者信息

Rönnblom Lars, Eloranta Maija-Leena, Alm Gunnar V

机构信息

Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden.

出版信息

Arthritis Rheum. 2006 Feb;54(2):408-20. doi: 10.1002/art.21571.

DOI:10.1002/art.21571

PMID:16447217

Abstract

摘要

相似文献

The type I interferon system in systemic lupus erythematosus.

Arthritis Rheum. 2006 Feb;54(2):408-20. doi: 10.1002/art.21571.

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010.

A compass that points to lupus: genetic studies on type I interferon pathway.

Genes Immun. 2007 Sep;8(6):445-55. doi: 10.1038/sj.gene.6364409. Epub 2007 Jun 21.

Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.

Arch Dermatol Res. 2009 Jan;301(1):83-6. doi: 10.1007/s00403-008-0892-8. Epub 2008 Sep 11.

Type I interferon and lupus.

Curr Opin Rheumatol. 2009 Sep;21(5):471-7. doi: 10.1097/BOR.0b013e32832e089e.

Targeting of type I interferon in systemic autoimmune diseases.

Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16.

[Interferon in the therapy of lupus erythematosus].

Vestn Dermatol Venerol. 1984 Apr(4):9-12.

Development of biologicals for the therapy of lupus erythematosus.

Expert Rev Vaccines. 2007 Dec;6(6):1001-11. doi: 10.1586/14760584.6.6.1001.

Systemic lupus erythematosus: all roads lead to type I interferons.

Curr Opin Immunol. 2006 Dec;18(6):676-82. doi: 10.1016/j.coi.2006.09.014. Epub 2006 Oct 2.

Type-I interferons and systemic lupus erythematosus.

Autoimmun Rev. 2006 Oct;5(8):554-62. doi: 10.1016/j.autrev.2006.05.002. Epub 2006 Jun 27.

引用本文的文献

Emerging roles of SLAMF7 in immune cells and related diseases.

Innate Immun. 2025 Jan-Dec;31:17534259251326700. doi: 10.1177/17534259251326700. Epub 2025 Mar 16.

Interferon Inhibition in SLE: From Bench to Bedside.

Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):354-364. doi: 10.31138/mjr.010324.iis. eCollection 2024 Jun.

Sirtuin 3 is required for the dexmedetomidine-mediated alleviation of inflammation and oxidative stress in nephritis.

Immun Inflamm Dis. 2024 Jan;12(1):e1135. doi: 10.1002/iid3.1135.

Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut.

Immun Inflamm Dis. 2023 Sep;11(9):e1005. doi: 10.1002/iid3.1005.

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE.

JCI Insight. 2023 Sep 21;8(20):e169344. doi: 10.1172/jci.insight.169344.

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.

Front Immunol. 2022 Dec 2;13:839197. doi: 10.3389/fimmu.2022.839197. eCollection 2022.

Sex bias in lymphocytes: Implications for autoimmune diseases.

Front Immunol. 2022 Nov 24;13:945762. doi: 10.3389/fimmu.2022.945762. eCollection 2022.

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting.

Biomedicines. 2022 Nov 4;10(11):2820. doi: 10.3390/biomedicines10112820.

COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection.

PLoS Genet. 2022 Nov 3;18(11):e1010253. doi: 10.1371/journal.pgen.1010253. eCollection 2022 Nov.

Impact of Siglecs on autoimmune diseases.

Mol Aspects Med. 2023 Apr;90:101140. doi: 10.1016/j.mam.2022.101140. Epub 2022 Aug 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The type I interferon system in systemic lupus erythematosus.

Arthritis Rheum. 2006 Feb;54(2):408-20. doi: 10.1002/art.21571.

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010.

A compass that points to lupus: genetic studies on type I interferon pathway.

Genes Immun. 2007 Sep;8(6):445-55. doi: 10.1038/sj.gene.6364409. Epub 2007 Jun 21.

Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.

Arch Dermatol Res. 2009 Jan;301(1):83-6. doi: 10.1007/s00403-008-0892-8. Epub 2008 Sep 11.

Type I interferon and lupus.

Curr Opin Rheumatol. 2009 Sep;21(5):471-7. doi: 10.1097/BOR.0b013e32832e089e.

Targeting of type I interferon in systemic autoimmune diseases.

Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16.

[Interferon in the therapy of lupus erythematosus].

Vestn Dermatol Venerol. 1984 Apr(4):9-12.

Development of biologicals for the therapy of lupus erythematosus.

Expert Rev Vaccines. 2007 Dec;6(6):1001-11. doi: 10.1586/14760584.6.6.1001.

Systemic lupus erythematosus: all roads lead to type I interferons.

Curr Opin Immunol. 2006 Dec;18(6):676-82. doi: 10.1016/j.coi.2006.09.014. Epub 2006 Oct 2.

Type-I interferons and systemic lupus erythematosus.

Autoimmun Rev. 2006 Oct;5(8):554-62. doi: 10.1016/j.autrev.2006.05.002. Epub 2006 Jun 27.

引用本文的文献

Emerging roles of SLAMF7 in immune cells and related diseases.

Innate Immun. 2025 Jan-Dec;31:17534259251326700. doi: 10.1177/17534259251326700. Epub 2025 Mar 16.

Interferon Inhibition in SLE: From Bench to Bedside.

Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):354-364. doi: 10.31138/mjr.010324.iis. eCollection 2024 Jun.

Sirtuin 3 is required for the dexmedetomidine-mediated alleviation of inflammation and oxidative stress in nephritis.

Immun Inflamm Dis. 2024 Jan;12(1):e1135. doi: 10.1002/iid3.1135.

Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut.

Immun Inflamm Dis. 2023 Sep;11(9):e1005. doi: 10.1002/iid3.1005.

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE.

JCI Insight. 2023 Sep 21;8(20):e169344. doi: 10.1172/jci.insight.169344.

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.

Front Immunol. 2022 Dec 2;13:839197. doi: 10.3389/fimmu.2022.839197. eCollection 2022.

Sex bias in lymphocytes: Implications for autoimmune diseases.

Front Immunol. 2022 Nov 24;13:945762. doi: 10.3389/fimmu.2022.945762. eCollection 2022.

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting.

Biomedicines. 2022 Nov 4;10(11):2820. doi: 10.3390/biomedicines10112820.

COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection.

PLoS Genet. 2022 Nov 3;18(11):e1010253. doi: 10.1371/journal.pgen.1010253. eCollection 2022 Nov.

Impact of Siglecs on autoimmune diseases.

Mol Aspects Med. 2023 Apr;90:101140. doi: 10.1016/j.mam.2022.101140. Epub 2022 Aug 30.